2026 Critical Care Congress Skip to main content
2026 Critical Care Congress Main banner
Final Program


Advance Program
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Session Icons
Thought Leader Session
Thought Leader Session
Guidelines Session
Guidelines Session
Aging Adult Track
Aging Adult Track
Additional Registration Fee
Additional Registration Fee

Research Snapshot Theater: Sepsis, Pediatric II

Developing a Sepsis Decision-Making Tool for Children With Cancer Using a Modified Delphi Consensus

Monday, March 23, 2026
10:15 AM - 11:15 AM Central Time
Location: Connections Central - RST 14

  • Eliana Lopez-Baron, N/A (she/her/hers)

    Antioquia, COL

    Disclosure(s): No relevant financial relationship(s) to disclose.

  • EF

    Eileen Fonseca, N/A

    Pediatric hematologist oncologist
    HOMI-Fundación Hospital la Misericordia, Colombia

    Disclosure information not submitted.

  • GC

    German Camacho-Moreno, N/A

    Pediatric Infectious disease
    HOMI-Fundación Hospital la Misericordia, Colombia

    Disclosure information not submitted.

  • CP

    Carlos Andres Portilla, N/A

    Pediatric hematologist oncologist
    Pediatric Hematology/Oncology Unit, Clinica Imbanaco, Colombia

    Disclosure information not submitted.

  • JA

    Javier Aguilar-Mejia, N/A

    Pediatrician
    HOMI-Fundación Hospital la Misericordia, Colombia

    Disclosure information not submitted.

  • JJ

    Juan Jaramillo-Bustamante, MD

    Pediatric Intensivist
    Hospital General de Medellín. Hospital Pablo Tobón Uribe., Colombia

    Disclosure information not submitted.

  • RL

    Ruben Lasso Palomino, MD

    Pediatric Critical Care Physician
    Maternal and Child Health Department. Fundación Valle del Lili, Colombia

    Disclosure information not submitted.

  • SB

    Santiago Bolivar, n/a

    Medical Student
    Pontificia Universidad Javeriana

    Disclosure information not submitted.

  • AD

    Alejandro Diaz-Diaz, MD

    Pediatric Infectious diseaserica
    Hospital General de Medellin. Hospital Pablo Tobón Uribe, Colombia

    Disclosure information not submitted.

  • LG

    Laura Galvis-Blanco, MD

    Pediatric Emergency
    Maternal and Child Health Department.Fundación Valle del Lili, Colombia

    Disclosure information not submitted.

  • JG

    JAVIER GODOY, MD

    Pediatric Critical care physician
    Instituto Nacional de Cancerología, Colombia

    Disclosure information not submitted.

  • PP

    Paola Perez, MD

    Pediatrica Infectious Disease
    Maternal and Child Health Department. Fundación Valle del Lili, Colombia

    Disclosure information not submitted.

  • RP

    Rodrigo Perez, MD

    Pediatric critical Care Physician
    HOMI-Fundación Hospital la Misericordia, Colombia

    Disclosure information not submitted.

  • OR

    Oscar Ramírez, MD

    Pediatrica Hematologist Oncologist
    Cali Population-Based Cancer Registry, Department of Pathology, Universidad del Valle, Colombia

    Disclosure information not submitted.

  • MT

    Margarita Torres, MD

    Pediatrician
    Department of Pediatrics and Critical Care. Clínica Imbanaco,, Colombia

    Disclosure information not submitted.

  • LT

    Leidy Tovar-Padua, MD

    Doctor
    University of California San Diego/Rady Children’s Hospital-San Diego

    Disclosure information not submitted.

  • PA

    Paula Aristizabal, MD

    Doctor
    University of California San Diego/Rady Children’s Hospital-San Diego

    Disclosure information not submitted.

Introduction: Despite initiatives aimed at improving outcomes for children with cancer, the survival gap between low-and middle- income countries (LMIC) and high-income countries remains substantial. In Colombia, a LMIC, sepsis represents 90% of treatment-related mortality. We aimed to reduce sepsis-related mortality in pediatric cancer patients through the development of a consensus-driven tool for early sepsis detection and treatment tailored to local context.


Methods: A decision-making tool was adapted through a structured three phase process over a period of approximately eight months.. Initially, a collaborative interprofessional team including professionals from eight Colombian institutions was established. The committee conducted a comprehensive literature review and convened biweekly to develop the National Protocol for Early-Sepsis Detection in Children with Cancer. In a second phase, a standardization of risk/alert concepts and evidence-based essential steps within a decision-making tool were established. A last step was to convene a multinational and international experts consensus from pertinent professional medical societies in Colombia, United States, and Mexico. The team utilized the RAND/UCLA Delphi methodology.


Results: A list of recommended clinical phenotypes, risk/alert criteria, essential steps, evidence-based therapies, and decision-making trees were developed. The expert advisory committee initially evaluated the items using an internet poll and subsequently gathered in a hybrid conference (both in-person and virtual) to review and assess 22 items within the decision-making tool. A consensus (≥80% agreement) was achieved on 21 out of 22 items following two rounds of evaluation. This agreement enabled contextual modifications of the decision-making tool, fostering the creation of user-friendly decision trees.


Conclusions: By reaching an interprofessional consensus, we adapted an evidence-based, user-friendly tool for early sepsis identification and treatment that is tailored to our local context. Subsequent steps entail employing quality improvement approaches to validate and implement the algorithm, and assess its predictive value. This strategy supports the goal of reducing treatment-related mortality associated with sepsis by enhancing the medical decision-making process.